Target portfolio structure
Rising Stars (TOP 1-5) — our portfolio
Rising Stars (TOP 6-15)
Try our mobile app
#reports #GOGL
[Golden Ocean](https://eninvs.com/all.php?name=GOGL) (Marine Shipping) reported for 2024 q4
(2025-02-26, Before Market Open):
- Revenue -42.5% YoY (vs -16.9% in previous quarter and historical rate -4.4%)
- EBITDA -90% YoY (vs -33.9% in previous quarter and historical rate +14.8%)
- EBITDA margin 8.5% decreased compared to 48.6% same period last year
- Net Debt increased by $87 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 8.4x compared to historical level (75th percentile) of 9.4x
- EV/Sales multiple is 3.4x
At the opening of the session the share price went up +2.6% vs S&P500 +0.2%
------------------------------------------------
#reports #UTMD
[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186229)
(2025-01-28, Before Market Open):
- Revenue -9.1% YoY (vs -25.0% in previous quarter and historical rate +3.0%)
- EBITDA -20% YoY (vs 0.0% in previous quarter and historical rate -4.2%)
- EBITDA margin 40.0% decreased compared to 45.5% same period last year
- Net Debt decreased by $300 mln over the past reporting period (150.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 151.3% of market cap
- EV/EBITDA multiple is 8.2x compared to historical level (75th percentile) of 12.8x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +1.4% vs S&P500 +0.5%
------------------------------------------------
#reports #SRTS
[Sensus Healthcare](https://eninvs.com/all.php?name=SRTS) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186124)
(2025-05-15, After Market Close):
- Revenue -27.3% YoY (vs 0.0% in previous quarter and historical rate +32.0%)
- EBITDA -200% YoY (vs -80.0% in previous quarter)
- EBITDA margin -37.5% decreased compared to 27.3% same period last year
- Net Debt decreased by $18 mln over the past reporting period (23.5% of market cap)
- FCF (LTM) +$0 bln (positive), 10.4% of market cap
- EV/EBITDA multiple is 18.3x compared to historical level (75th percentile) of 8.6x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -4.7% vs S&P500 +0.2%
------------------------------------------------
#reports #RHE
[Regional Health Properties](https://eninvs.com/all.php?name=RHE) (Medical Care Facilities) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186128)
(2025-04-03, After Market Close):
- Revenue +75% YoY (vs +20.0% in previous quarter and historical rate +6.8%)
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 1.7x
------------------------------------------------
#reports #POLA
[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186170)
(2024-11-15, After Market Close):
- Revenue 0% YoY (vs -25.0% in previous quarter and historical rate +8.2%)
- EBITDA margin -50.0% increased compared to -100.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (21.2% of market cap)
- FCF (LTM) +$0 bln (positive), 21.2% of market cap
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +599.7% vs S&P500 +0.2%
------------------------------------------------
#reports #NEPH
[Nephros](https://eninvs.com/all.php?name=NEPH) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186139)
(2025-05-08, Before Market Open):
- Revenue +25% YoY (vs +33.3% in previous quarter and historical rate +25.0%)
- EBITDA margin 20.0% increased compared to 0.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went up +0.5% vs S&P500 +0.6%
------------------------------------------------
#reports #MYSZ
[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186140)
(2022-11-17):
- Revenue -66.7% YoY (vs -66.7% in previous quarter and historical rate +88.9%)
- EBITDA margin -100.0% decreased compared to -33.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (72.0% of market cap)
- FCF (LTM) -$0 bln (negative), 72.0% of market cap
- EV/Sales multiple is 0.2x
------------------------------------------------
#reports #MITQ
[Moving iMage Technologies, Inc.](https://eninvs.com/all.php?name=MITQ) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186191)
(2023-02-14, Before Market Open):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +23.5%)
- EV/EBITDA multiple is 1.8x compared to historical level (75th percentile) of 7x
- EV/Sales multiple is 0.1x
At the opening of the session the share price went up +6.3%
------------------------------------------------
#reports #GTEC
[Greenland Technologies Corporation](https://eninvs.com/all.php?name=GTEC) (Specialty Industrial Machinery) reported for 2025 q1
(2025-05-15, After Market Close):
- Revenue -4.3% YoY (vs -17.4% in previous quarter and historical rate -10.7%)
- EBITDA +150% YoY (vs +33.3% in previous quarter and historical rate +17.6%)
- EBITDA margin 22.7% increased compared to 8.7% same period last year
- Net Debt increased by $6 mln over the past reporting period (18.5% of market cap)
- FCF (LTM) +$0 bln (positive), 61.6% of market cap
- EV/EBITDA multiple is 0.4x compared to historical level (75th percentile) of 1.6x
- EV/Sales multiple is 0.1x
At the opening of the session the share price went down -1.5% vs S&P500 +0.2%
------------------------------------------------
#reports #FBIOP
[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186154):
- Revenue 0% YoY (vs -25.0% in previous quarter and historical rate -0.5%)
- EBITDA margin 92.3% increased compared to -15.4% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 13.1% of market cap
- EV/Sales multiple is 2.2x
------------------------------------------------
#reports #DOCS
[Doximity, Inc.](https://eninvs.com/all.php?name=DOCS) (Health Information Services) reported for 2025 q1
(2025-05-15, After Market Close):
- Revenue +16.9% YoY (vs +25.2% in previous quarter and historical rate +18.6%)
- EBITDA +18.2% YoY (vs +36.1% in previous quarter and historical rate +27.3%)
- EBITDA margin 37.7% increased compared to 37.3% same period last year
- Net Debt decreased by $71 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 41.8x compared to historical level (75th percentile) of 45x
- EV/Sales multiple is 17.6x
------------------------------------------------
#reports #CLRO
[ClearOne](https://eninvs.com/all.php?name=CLRO) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186235)
(2025-05-27, Before Market Open):
- Revenue -50% YoY (vs -25.0% in previous quarter and historical rate -28.3%)
- EBITDA margin -150.0% decreased compared to -50.0% same period last year
- EV/Sales multiple is 1.2x
------------------------------------------------
#reports #BFRI
[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186214)
(2023-08-11, Before Market Open):
- Revenue +12.5% YoY (vs +8.8% in previous quarter and historical rate +32.6%)
- EBITDA margin -55.6% increased compared to -62.5% same period last year
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -1.9%
------------------------------------------------
#reports #TTWO
@ gaming
[Take-Two Interactive Software](https://eninvs.com/all.php?name=TTWO) (Game developer) reported for 2025 q1
(2025-05-15, After Market Close):
- Revenue +13.2% YoY (vs -0.4% in previous quarter and historical rate +19.5%)
- EBITDA margin -228.9% decreased compared to -183.8% same period last year
- Net Debt decreased by $254 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.3% of market cap
- EV/Sales multiple is 7.4x
At the opening of the session the share price went up +1.8% vs S&P500 +0.2%
------------------------------------------------
#reports #NTES
@ china
[NetEase](https://eninvs.com/all.php?name=NTES) (IT services and products provider) reported for 2025 q1
(2025-05-15, Before Market Open):
- Revenue +6.8% YoY (vs -4.2% in previous quarter and historical rate +4.1%)
- EBITDA +32.7% YoY (vs +10.1% in previous quarter and historical rate +15.1%)
- EBITDA margin 37.9% increased compared to 30.5% same period last year
- Net Debt decreased by $747 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$2.7 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 14.2x
- EV/Sales multiple is 4.3x
At the opening of the session the share price went up +8.2% vs S&P500 -0.4%
------------------------------------------------
#reports #VNRX
[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186099)
(2025-05-16, Before Market Open):
- Revenue +43% YoY (vs -21.3% in previous quarter and historical rate +134.2%)
- EBITDA margin -2142.3% increased compared to -4721.5% same period last year
- Net Debt increased by $2.1 bln since the start of the year (5449.6% of market cap)
- FCF (LTM) -$10.8 bln (negative), 27548.7% of market cap
- EV/Sales multiple is 2.8x
------------------------------------------------
#reports #BEEM
@ renewable-energy
[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for 2025 q1
(2025-04-11, After Market Close):
- Revenue -60% YoY (vs -60.0% in previous quarter and historical rate +82.7%)
- EBITDA margin -233.3% decreased compared to -13.3% same period last year
- Net Debt increased by $2 mln over the past reporting period (6.9% of market cap)
- FCF (LTM) +$0 bln (positive), 3.5% of market cap
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +11.4% vs S&P500 +1.5%
------------------------------------------------
#reports #BABA
@ china , @ e-commerce
[Alibaba](https://eninvs.com/all.php?name=BABA) (Chinese e-commerce giant) reported for 2025 q1
(2025-05-15, Before Market Open):
- Revenue +6% YoY (vs +4.7% in previous quarter and historical rate +1.4%)
- EBITDA +56.5% YoY (vs +49.0% in previous quarter and historical rate +23.7%)
- EBITDA margin 15.9% increased compared to 10.8% same period last year
- Net Debt increased by $1.4 bln since the start of the year (0.4% of market cap)
- FCF (LTM) -$15.9 bln (negative), 4.9% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 11.9x
- EV/Sales multiple is 2.2x
At the opening of the session the share price went down -5.8% vs S&P500 -0.4%
------------------------------------------------
#reports #SYPR
[Sypris Solutions](https://eninvs.com/all.php?name=SYPR) (Auto Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186088)
(2025-05-20, Before Market Open):
- Revenue -16.7% YoY (vs -5.7% in previous quarter and historical rate +12.7%)
- EBITDA margin 3.3% increased compared to -2.8% same period last year
- Net Debt increased by $6 mln over the past reporting period (16.3% of market cap)
- FCF (LTM) -$0 bln (negative), 8.1% of market cap
- EV/EBITDA multiple is 6.1x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #STE
[STERIS](https://eninvs.com/all.php?name=STE) (Medical equipment supplier) reported for 2025 q1
(2025-05-14, After Market Close):
- Revenue +4.4% YoY (vs -1.8% in previous quarter and historical rate +6.3%)
- EBITDA -1.8% YoY (vs +5.3% in previous quarter and historical rate +26.0%)
- EBITDA margin 28.8% decreased compared to 30.7% same period last year
- Net Debt increased by $35 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 15.7x compared to historical level (75th percentile) of 25.5x
- EV/Sales multiple is 4.1x
------------------------------------------------
#reports #SEAS
[SeaWorld Entertainment](https://eninvs.com/all.php?name=SEAS) (Theme park owner) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186095)
(2023-11-08, Before Market Open):
- Revenue -3.4% YoY (vs -1.3% in previous quarter and historical rate +2.3%)
- EBITDA -3.3% YoY (vs -7.8% in previous quarter and historical rate +12.4%)
- EBITDA margin 20.6% has not changed compared to 20.5% same period last year
- Net Debt increased by $2.3 bln since the start of the year (82.5% of market cap)
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.9x
At the opening of the session the share price went up +1.7%
------------------------------------------------
#reports #RSKD
[Riskified Ltd.](https://eninvs.com/all.php?name=RSKD) (Software — Application) reported for 2025 q1
(2025-05-14, Before Market Open):
- Revenue +7.9% YoY (vs +11.9% in previous quarter and historical rate +11.9%)
- EBITDA margin -15.9% has not changed compared to -15.8% same period last year
- Net Debt increased by $18 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.2% of market cap
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -6.3% vs S&P500 +0.2%
------------------------------------------------
#reports #REKR
[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185988)
(2025-05-14, After Market Close):
- Revenue -10% YoY (vs +18.2% in previous quarter and historical rate +54.5%)
- EBITDA margin -100.0% increased compared to -120.0% same period last year
- Net Debt decreased by $10 mln over the past reporting period (19.7% of market cap)
- FCF (LTM) +$0 bln (positive), 3.9% of market cap
- EV/Sales multiple is 1.4x
------------------------------------------------
#reports #PRPO
[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186000)
(2023-11-13, After Market Close):
- Revenue +66.7% YoY (vs +25.0% in previous quarter and historical rate +54.2%)
- Net Debt increased by $1 mln over the past reporting period (0.6% of market cap)
- EV/Sales multiple is 8.5x
At the opening of the session the share price went down -7.1%
------------------------------------------------
#reports #OPTN
[OptiNose](https://eninvs.com/all.php?name=OPTN) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186025)
(2025-03-26, Before Market Open):
- Revenue +120% YoY (vs +10.0% in previous quarter and historical rate +18.3%)
- EBITDA margin -24.2% increased compared to -53.3% same period last year
- Net Debt increased by $28 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/Sales multiple is 18x
------------------------------------------------
#reports #NAII
[Natural Alternatives International](https://eninvs.com/all.php?name=NAII) (Packaged Foods) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186083)
(2025-02-18, After Market Close):
- Revenue +16% YoY (vs +36.0% in previous quarter and historical rate +5.0%)
- EBITDA margin -3.4% increased compared to -4.0% same period last year
- Net Debt decreased by $5 mln over the past reporting period (26.1% of market cap)
- FCF (LTM) -$0 bln (negative), 52.3% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -1.0% vs S&P500 +0.1%
------------------------------------------------
#reports #GWRS
[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for 2025 q1
(2025-05-14, After Market Close):
- Revenue 0% YoY (vs +108.3% in previous quarter and historical rate +16.9%)
- EBITDA +25% YoY (vs -40.0% in previous quarter and historical rate +16.4%)
- EBITDA margin 41.7% increased compared to 33.3% same period last year
- EV/EBITDA multiple is 17.5x compared to historical level (75th percentile) of 20x
- EV/Sales multiple is 5.7x
------------------------------------------------
#reports #GLBE
[Global-e Online Ltd.](https://eninvs.com/all.php?name=GLBE) (Internet Retail) reported for 2025 q1
(2025-05-14, Before Market Open):
- Revenue +30.1% YoY (vs +42.2% in previous quarter and historical rate +35.6%)
- EBITDA margin -10.0% increased compared to -19.9% same period last year
- Net Debt increased by $29 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/Sales multiple is 6.2x
At the opening of the session the share price went down -22.3% vs S&P500 +0.2%
------------------------------------------------
#reports #EWCZ
[European Wax Center, Inc.](https://eninvs.com/all.php?name=EWCZ) (Household and Personal Products) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185975)
(2025-05-14, Before Market Open):
- Revenue -1.9% YoY (vs -10.7% in previous quarter and historical rate +20.2%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +27.5%)
- EBITDA margin 31.4% increased compared to 30.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 23.7x
- EV/Sales multiple is 3.1x
At the opening of the session the share price went up +15.9% vs S&P500 +0.2%
------------------------------------------------
#reports #EGAN
[eGain](https://eninvs.com/all.php?name=EGAN) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185973)
(2025-05-14, After Market Close):
- Revenue -4.5% YoY (vs -8.3% in previous quarter and historical rate +16.2%)
- Net Debt increased by $2 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 4.8% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 62x
- EV/Sales multiple is 0.6x
------------------------------------------------
#reports #DT
[Dynatrace](https://eninvs.com/all.php?name=DT) (Software provider) reported for 2025 q1
(2025-05-14, Before Market Open):
- Revenue +16.8% YoY (vs +19.5% in previous quarter and historical rate +22.3%)
- EBITDA +70.3% YoY (vs +52.5% in previous quarter and historical rate +48.1%)
- EBITDA margin 14.2% increased compared to 9.7% same period last year
- Net Debt decreased by $106 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 62x compared to historical level (75th percentile) of 100.4x
- EV/Sales multiple is 8.8x
At the opening of the session the share price went up +2.0% vs S&P500 +0.2%
------------------------------------------------
#reports #DRIO
[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185971)
(2025-05-14, Before Market Open):
- Revenue +16.7% YoY (vs +100.0% in previous quarter and historical rate +30.8%)
- EBITDA -44.4% YoY (vs -14.3% in previous quarter and historical rate +69.9%)
- EBITDA margin 142.9% decreased compared to 300.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (92.8% of market cap)
- FCF (LTM) -$0 bln (negative), 39.8% of market cap
- EV/Sales multiple is -0.7x
At the opening of the session the share price went down -7.1% vs S&P500 +0.2%
------------------------------------------------
#reports #DERM
[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for 2025 q1
(2025-05-14, After Market Close):
- Revenue 0% YoY (vs -6.7% in previous quarter and historical rate -6.0%)
- EBITDA margin -30.8% increased compared to -84.6% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 11.4% of market cap
- EV/Sales multiple is 2.2x
------------------------------------------------
#reports #CDXS
[Codexis](https://eninvs.com/all.php?name=CDXS) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185968)
(2025-05-14, After Market Close):
- Revenue -52.9% YoY (vs -22.2% in previous quarter and historical rate -15.8%)
- EBITDA margin -225.0% decreased compared to -52.9% same period last year
- Net Debt increased by $14 mln over the past reporting period (8.7% of market cap)
- EV/Sales multiple is 2.9x
------------------------------------------------
#reports #CAAS
[China Automotive Systems](https://eninvs.com/all.php?name=CAAS) (Auto Parts) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185967)
(2025-05-14, Before Market Open):
- Revenue +20.1% YoY (vs +18.9% in previous quarter and historical rate +11.1%)
- EBITDA -13.3% YoY (vs -26.3% in previous quarter and historical rate +26.1%)
- EBITDA margin 7.8% decreased compared to 10.8% same period last year
- Net Debt increased by $97 mln over the past reporting period (78.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 50.7% of market cap
- EV/EBITDA multiple is 2.1x compared to historical level (75th percentile) of 2.2x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +6.6% vs S&P500 +0.2%
------------------------------------------------
#reports #AYTU
[Aytu Biopharma](https://eninvs.com/all.php?name=AYTU) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=186015)
(2023-05-15, After Market Close):
- Revenue 0% YoY (vs -30.4% in previous quarter and historical rate +8.4%)
- EBITDA margin 22.2% increased compared to -5.6% same period last year
- Net Debt increased by $5 mln over the past reporting period (60.4% of market cap)
- FCF (LTM) +$0 bln (positive), 84.6% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -1.1%
------------------------------------------------
#reports #ABUS
[Arbutus Biopharma Corporation](https://eninvs.com/all.php?name=ABUS) (Biotechnology) reported for 2025 q1
(2025-05-12, Before Market Open):
- Revenue 0% YoY (vs +150.0% in previous quarter and historical rate +13.7%)
- EBITDA margin -1200.0% decreased compared to -900.0% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) -$0 bln (negative), 5.0% of market cap
- EV/Sales multiple is 33.6x
At the opening of the session the share price went up +2.2% vs S&P500 +2.6%
------------------------------------------------
#reports #YMAB
[Y-mAbs Therapeutics](https://eninvs.com/all.php?name=YMAB) (Therapeutic drug developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185736)
(2025-03-04, Before Market Open):
- Revenue +5% YoY (vs +13.0% in previous quarter and historical rate +40.1%)
- EBITDA margin -28.6% increased compared to -35.0% same period last year
- Net Debt increased by $6 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0 bln (negative), 8.1% of market cap
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -15.6% vs S&P500 -0.3%
------------------------------------------------
#reports #XTNT
[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185867)
(2025-05-12, After Market Close):
- Revenue +17.9% YoY (vs +14.3% in previous quarter and historical rate +32.8%)
- EBITDA margin 6.1% increased compared to -7.1% same period last year
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +13.5% vs S&P500 +0.2%
------------------------------------------------
#reports #XBIO
[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185770)
(2023-08-11, Before Market Open):
- Revenue +16% YoY (vs -3.4% in previous quarter and historical rate +79.2%)
- EBITDA +93.1% YoY (vs -110000.0% in previous quarter)
- EBITDA margin 114.0% increased compared to 68.5% same period last year
- Net Debt increased by $1 bln since the start of the year (21244.6% of market cap)
- FCF (LTM) -$2.7 bln (negative), 56397.8% of market cap
- EV/EBITDA multiple is 4.6x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -2x
At the opening of the session the share price went up +6.9%
------------------------------------------------
#reports #VRME
[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185733)
(2025-05-12, Before Market Open):
- Revenue -33.3% YoY (vs -11.1% in previous quarter and historical rate +64.5%)
- EBITDA 0% YoY (vs -16.7% in previous quarter)
- EBITDA margin 75.0% increased compared to 50.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (81.2% of market cap)
- FCF (LTM) +$0 bln (positive), 81.2% of market cap
- EV/EBITDA multiple is 0.3x compared to historical level (75th percentile) of 1.5x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +7.0% vs S&P500 +2.6%
------------------------------------------------
#reports #URGN
[UroGen Pharma](https://eninvs.com/all.php?name=URGN) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185902)
(2025-05-12, Before Market Open):
- Revenue +5.3% YoY (vs +4.2% in previous quarter and historical rate +20.3%)
- EBITDA margin -185.0% decreased compared to -136.8% same period last year
- Net Debt increased by $42 mln over the past reporting period (9.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/Sales multiple is 4x
At the opening of the session the share price went down -4.6% vs S&P500 +2.6%
------------------------------------------------
#reports #UPLD
[Upland Software](https://eninvs.com/all.php?name=UPLD) (Software — Application) reported for 2025 q1
(2025-03-12, Before Market Open):
- Revenue -9.9% YoY (vs -5.6% in previous quarter and historical rate -4.3%)
- EBITDA margin 17.2% increased compared to -105.6% same period last year
- Net Debt increased by $42 mln over the past reporting period (55.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 418.9% of market cap
- EV/EBITDA multiple is 17.3x compared to historical level (75th percentile) of 1608x
- EV/Sales multiple is 3.3x
At the opening of the session the share price went down -4.5% vs S&P500 +0.9%
------------------------------------------------
#reports #TPIC
[TPI Composites](https://eninvs.com/all.php?name=TPIC) (Industrial company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185869)
(2025-05-08, After Market Close):
- Revenue +12.4% YoY (vs +14.8% in previous quarter and historical rate -6.1%)
- EBITDA margin -4.8% increased compared to -10.0% same period last year
- Net Debt increased by $18 mln over the past reporting period (36.4% of market cap)
- FCF (LTM) -$0 bln (negative), 64.7% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went up +3.0% vs S&P500 +0.3%
------------------------------------------------
#reports #TACT
[TransAct Technologies](https://eninvs.com/all.php?name=TACT) (Computer Hardware) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue +18.2% YoY (vs -23.1% in previous quarter and historical rate +15.2%)
- EV/EBITDA multiple is 25.4x compared to historical level (75th percentile) of 16.3x
- EV/Sales multiple is 0.6x
------------------------------------------------
#reports #SSTI
[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue +12% YoY (vs -11.5% in previous quarter and historical rate +23.2%)
- EBITDA margin -3.6% increased compared to -12.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 3.5% of market cap
- EV/EBITDA multiple is 190.4x compared to historical level (75th percentile) of 34x
- EV/Sales multiple is 1.8x
------------------------------------------------
#reports #SND
[Smart Sand](https://eninvs.com/all.php?name=SND) (Oil and Gas Equipment and Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185730)
(2025-05-13, After Market Close):
- Revenue -20.5% YoY (vs +46.8% in previous quarter and historical rate +38.0%)
- EBITDA margin -9.1% decreased compared to 1.2% same period last year
- Net Debt decreased by $9 mln over the past reporting period (10.7% of market cap)
- FCF (LTM) +$0 bln (positive), 10.7% of market cap
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #SMWB
[Similarweb Ltd.](https://eninvs.com/all.php?name=SMWB) (Internet Content and Information) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue +13.6% YoY (vs +15.8% in previous quarter and historical rate +14.1%)
- EBITDA margin -13.4% decreased compared to -5.1% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/Sales multiple is 2.3x
------------------------------------------------
#reports #SBH
[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185857)
(2025-05-12, Before Market Open):
- Revenue -2.8% YoY (vs +0.8% in previous quarter and historical rate -1.7%)
- EBITDA 0% YoY (vs +41.6% in previous quarter and historical rate -0.9%)
- EBITDA margin 10.8% increased compared to 10.5% same period last year
- Net Debt decreased by $16 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 10.2% of market cap
- EV/EBITDA multiple is 5.9x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +9.4% vs S&P500 +2.6%
------------------------------------------------
#reports #RICK
[RCI Hospitality](https://eninvs.com/all.php?name=RICK) (Restaurants) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185961)
(2025-05-12, After Market Close):
- Revenue -8.3% YoY (vs -4.1% in previous quarter and historical rate +26.6%)
- EBITDA +33.3% YoY (vs 0.0% in previous quarter and historical rate +3.0%)
- EBITDA margin 18.2% increased compared to 12.5% same period last year
- Net Debt increased by $7 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 19.8x compared to historical level (75th percentile) of 14x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +6.0% vs S&P500 +0.2%
------------------------------------------------
#reports #RGNX
[REGENXBIO](https://eninvs.com/all.php?name=RGNX) (Developer of viral gene therapy) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185889)
(2025-03-13, After Market Close):
- Revenue +456.3% YoY (vs -4.5% in previous quarter and historical rate +3.6%)
- EBITDA margin 18.0% increased compared to -375.0% same period last year
- Net Debt decreased by $35 mln over the past reporting period (8.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.2% of market cap
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +7.9% vs S&P500 +0.8%
------------------------------------------------
#reports #QUIK
[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue -33.3% YoY (vs -14.3% in previous quarter and historical rate +16.9%)
- EBITDA margin -50.0% decreased compared to 0.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0 bln (negative), 6.2% of market cap
- EV/Sales multiple is 5.5x
------------------------------------------------
#reports #QRHC
[Quest Resource Corporation](https://eninvs.com/all.php?name=QRHC) (Waste Management) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185865)
(2025-05-12, After Market Close):
- Revenue -6.8% YoY (vs +1.4% in previous quarter and historical rate +23.9%)
- EBITDA -250% YoY (vs -350.0% in previous quarter)
- EBITDA margin -8.8% decreased compared to 5.5% same period last year
- Net Debt decreased by $4 mln over the past reporting period (8.2% of market cap)
- FCF (LTM) -$0 bln (negative), 10.2% of market cap
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -6.9% vs S&P500 +0.2%
------------------------------------------------
#reports #PXLW
[Pixelworks](https://eninvs.com/all.php?name=PXLW) (Semiconductors) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue -56.3% YoY (vs -55.0% in previous quarter and historical rate -10.8%)
- EBITDA margin -100.0% decreased compared to -25.0% same period last year
- Net Debt increased by $5 mln over the past reporting period (14.3% of market cap)
- FCF (LTM) -$0 bln (negative), 22.9% of market cap
- EV/Sales multiple is 1.9x
------------------------------------------------
#reports #POWI
[Power Integrations](https://eninvs.com/all.php?name=POWI) (Analog integrated circuits manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185945)
(2025-05-12, After Market Close):
- Revenue +15.2% YoY (vs +16.7% in previous quarter and historical rate -13.5%)
- EBITDA +40% YoY (vs +50.0% in previous quarter and historical rate -24.9%)
- EBITDA margin 13.2% increased compared to 10.9% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 50.1x compared to historical level (75th percentile) of 57.6x
- EV/Sales multiple is 6.6x
At the opening of the session the share price went down -0.8% vs S&P500 +0.2%
------------------------------------------------
#reports #PENN
[Penn National Gaming](https://eninvs.com/all.php?name=PENN) (Provider of entertainment services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185959)
(2025-05-08, Before Market Open):
- Revenue +4.1% YoY (vs +19.6% in previous quarter and historical rate +2.6%)
- EBITDA +73.6% YoY (vs +5800.0% in previous quarter and historical rate -6.4%)
- EBITDA margin 9.0% increased compared to 5.4% same period last year
- Net Debt decreased by $115 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.6% of market cap
- EV/EBITDA multiple is 18.5x compared to historical level (75th percentile) of 12.6x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went down -0.7% vs S&P500 +0.6%
------------------------------------------------
#reports #NUWE
[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185767)
(2023-05-09):
- Revenue 0% YoY (vs -33.3% in previous quarter and historical rate -1.4%)
- EBITDA margin -150.0% increased compared to -250.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (15.9% of market cap)
- FCF (LTM) +$0 bln (positive), 31.8% of market cap
- EV/Sales multiple is 1.4x
------------------------------------------------
#reports #NRG
[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185832)
(2025-05-12, Before Market Open):
- Revenue +15.6% YoY (vs +0.2% in previous quarter and historical rate +8.2%)
- EBITDA +28.1% YoY (vs -9.9% in previous quarter and historical rate +17.9%)
- EBITDA margin 17.0% increased compared to 15.3% same period last year
- Net Debt decreased by $28 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 12.9x compared to historical level (75th percentile) of 9.9x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +14.8% vs S&P500 +2.6%
------------------------------------------------
#reports #NPCE
[NeuroPace, Inc.](https://eninvs.com/all.php?name=NPCE) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185722)
(2025-05-13, After Market Close):
- Revenue +27.8% YoY (vs +300.0% in previous quarter and historical rate +40.5%)
- EBITDA margin -21.7% increased compared to -38.9% same period last year
- Net Debt decreased by $14 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/Sales multiple is 2.4x
------------------------------------------------
#reports #NGS
[Natural Gas Services Group](https://eninvs.com/all.php?name=NGS) (Oil and Gas Equipment and Services) reported for 2025 q1
(2025-05-12, After Market Close):
- Revenue +10.8% YoY (vs +116.7% in previous quarter and historical rate +38.9%)
- EBITDA +12.5% YoY (vs +100.0% in previous quarter and historical rate +65.6%)
- EBITDA margin 43.9% increased compared to 43.2% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 5.8x compared to historical level (75th percentile) of 8.9x
- EV/Sales multiple is 2.4x
At the opening of the session the share price went up +7.8% vs S&P500 +0.2%
------------------------------------------------
#reports #MASS
[908 Devices Inc.](https://eninvs.com/all.php?name=MASS) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185718)
(2025-05-13, Before Market Open):
- Revenue +20% YoY (vs +35.7% in previous quarter and historical rate +23.1%)
- EBITDA margin -83.3% increased compared to -120.0% same period last year
- Net Debt decreased by $58 mln over the past reporting period (36.0% of market cap)
- FCF (LTM) -$0 bln (negative), 6.8% of market cap
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +1.9% vs S&P500 +0.2%
------------------------------------------------
#reports #LSTR
[Landstar System](https://eninvs.com/all.php?name=LSTR) (Logistic services provider) reported for 2025 q1
(2025-05-13, Before Market Open):
- Revenue -1.5% YoY (vs +0.4% in previous quarter and historical rate -11.2%)
- EBITDA -29.7% YoY (vs +7000.0% in previous quarter and historical rate -6.6%)
- EBITDA margin 4.5% decreased compared to 6.3% same period last year
- Net Debt increased by $85 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.0% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 23x
- EV/Sales multiple is 1x
At the opening of the session the share price went up +2.9% vs S&P500 +0.2%
------------------------------------------------
#reports #KPTI
[Karyopharm Therapeutics](https://eninvs.com/all.php?name=KPTI) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185713)
(2025-05-01, Before Market Open):
- Revenue -9.1% YoY (vs -8.8% in previous quarter and historical rate -3.3%)
- EBITDA margin -110.0% decreased compared to -100.0% same period last year
- Net Debt increased by $31 mln over the past reporting period (5.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 15.5% of market cap
- EV/Sales multiple is 5.1x
------------------------------------------------
#reports #IRIX
[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185711)
(2025-05-13, After Market Close):
- Revenue 0% YoY (vs +8.3% in previous quarter and historical rate +0.1%)
- Net Debt increased by $38 mln over the past reporting period (210.1% of market cap)
- FCF (LTM) -$0 bln (negative), 237.8% of market cap
- EV/Sales multiple is 1.2x
------------------------------------------------
#reports #IDN
[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue 0% YoY (vs +200.0% in previous quarter and historical rate +24.4%)
- EV/Sales multiple is 1.7x
------------------------------------------------
#reports #ICAD
[iCAD](https://eninvs.com/all.php?name=ICAD) (Health Information Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185816)
(2025-05-13, After Market Close):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -16.0%)
- EBITDA margin -20.0% has not changed compared to -20.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (3.0% of market cap)
- EV/Sales multiple is 4.2x
------------------------------------------------
#reports #IAS
[Integral Ad Science Holding Corp.](https://eninvs.com/all.php?name=IAS) (Advertising Agencies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185924)
(2025-05-12, After Market Close):
- Revenue +16.5% YoY (vs +14.2% in previous quarter and historical rate +17.2%)
- EBITDA +75% YoY (vs +35.5% in previous quarter and historical rate +55.0%)
- EBITDA margin 20.9% increased compared to 13.9% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 9.5x compared to historical level (75th percentile) of 40.7x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +3.7% vs S&P500 +0.2%
------------------------------------------------
#reports #HYFM
[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for 2025 q1
(2025-05-07, Before Market Open):
- Revenue -24.1% YoY (vs -21.3% in previous quarter and historical rate -27.6%)
- EBITDA -28.6% YoY (vs -25.0% in previous quarter and historical rate +40.0%)
- EBITDA margin 12.2% decreased compared to 13.0% same period last year
- Net Debt increased by $11 mln over the past reporting period (7.2% of market cap)
- FCF (LTM) +$0 bln (positive), 7.9% of market cap
- EV/EBITDA multiple is 153.3x compared to historical level (75th percentile) of 84.3x
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +8.4% vs S&P500 +0.1%
------------------------------------------------
#reports #HSON
[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for 2025 q1
(2025-05-13, Before Market Open):
- Revenue -5.9% YoY (vs +202.9% in previous quarter and historical rate +8.4%)
- EBITDA margin -3.1% increased compared to -8.8% same period last year
- Net Debt decreased by $16 mln over the past reporting period (56.1% of market cap)
- FCF (LTM) -$0 bln (negative), 14.0% of market cap
- EV/Sales multiple is 0.1x
At the opening of the session the share price went down -1.0% vs S&P500 +0.2%
------------------------------------------------
#reports #GPRO
[GoPro](https://eninvs.com/all.php?name=GPRO) (Technological equipment manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185873)
(2025-05-12, After Market Close):
- Revenue -13.5% YoY (vs -31.9% in previous quarter and historical rate -12.3%)
- EBITDA margin -32.1% decreased compared to -25.8% same period last year
- Net Debt increased by $58 mln over the past reporting period (63.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 92.3% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -5.0% vs S&P500 +0.2%
------------------------------------------------
#reports #FTHM
[Fathom](https://eninvs.com/all.php?name=FTHM) (Real Estate Services) reported for 2025 q1
(2025-05-13, After Market Close):
- Revenue +31% YoY (vs +24.3% in previous quarter and historical rate -4.8%)
- EBITDA margin -3.2% increased compared to -5.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (19.3% of market cap)
- FCF (LTM) -$0 bln (negative), 29.0% of market cap
- EV/Sales multiple is 0.1x
------------------------------------------------
#reports #FTEK
[Fuel Tech](https://eninvs.com/all.php?name=FTEK) (Pollution and Treatment Controls) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185946)
(2025-05-12, After Market Close):
- Revenue +20% YoY (vs -16.7% in previous quarter and historical rate +3.1%)
- EBITDA margin -16.7% increased compared to -40.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) -$0 bln (negative), 6.1% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +3.4% vs S&P500 +0.2%
------------------------------------------------
#reports #FF
[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185855)
(2024-11-08, After Market Close):
- Revenue -69% YoY (vs -32.6% in previous quarter and historical rate -6.7%)
- EBITDA -420% YoY (vs -82.6% in previous quarter)
- EBITDA margin -88.9% decreased compared to 8.6% same period last year
- Net Debt increased by $9 mln over the past reporting period (4.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 46.3% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -9.5% vs S&P500 +0.2%
------------------------------------------------
#reports #EXEL
[Exelixis](https://eninvs.com/all.php?name=EXEL) (Cancer Treatment manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185700)
(2025-05-13, After Market Close):
- Revenue +30.6% YoY (vs +18.1% in previous quarter and historical rate +15.5%)
- EBITDA +397.4% YoY (vs +94.3% in previous quarter and historical rate +50.4%)
- EBITDA margin 35.0% increased compared to 9.2% same period last year
- Net Debt decreased by $844 mln over the past reporting period (7.9% of market cap)
- FCF (LTM) +$1.2 bln (positive), 11.1% of market cap
- EV/EBITDA multiple is 12.5x compared to historical level (75th percentile) of 37.3x
- EV/Sales multiple is 4.3x
------------------------------------------------
#reports #EVI
[EVI Industries](https://eninvs.com/all.php?name=EVI) (Industrial Distribution) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185934)
(2025-05-12, Before Market Open):
- Revenue +11.9% YoY (vs +2.2% in previous quarter and historical rate +15.2%)
- EBITDA 0% YoY (vs 0.0% in previous quarter and historical rate +30.0%)
- EBITDA margin 4.3% decreased compared to 4.8% same period last year
- Net Debt decreased by $6 mln over the past reporting period (2.7% of market cap)
- FCF (LTM) -$0 bln (negative), 2.3% of market cap
- EV/EBITDA multiple is 12.4x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 0.7x
At the opening of the session the share price went up +5.5% vs S&P500 +2.6%
------------------------------------------------
#reports #ETON
[Eton Pharmaceuticals](https://eninvs.com/all.php?name=ETON) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185698)
(2025-05-13, After Market Close):
- Revenue +112.5% YoY (vs +71.4% in previous quarter and historical rate +63.5%)
- EBITDA margin 5.9% increased compared to -12.5% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 455x compared to historical level (75th percentile) of 89x
- EV/Sales multiple is 9.5x
------------------------------------------------
#reports #ENTA
[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q1
(2025-05-12, After Market Close):
- Revenue -11.8% YoY (vs -5.6% in previous quarter and historical rate -2.9%)
- EBITDA margin -160.0% increased compared to -188.2% same period last year
- Net Debt increased by $25 mln over the past reporting period (22.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 84.6% of market cap
- EV/EBITDA multiple is 0.2x compared to historical level (75th percentile) of 0.9x
- EV/Sales multiple is -0.3x
At the opening of the session the share price went down -0.7% vs S&P500 +0.2%
------------------------------------------------
#reports #DVA
[DaVita](https://eninvs.com/all.php?name=DVA) (Medical services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185960)
(2025-05-12, After Market Close):
- Revenue +5% YoY (vs +4.7% in previous quarter and historical rate +3.8%)
- EBITDA +15.8% YoY (vs +26.3% in previous quarter and historical rate +14.7%)
- EBITDA margin 19.1% increased compared to 17.3% same period last year
- Net Debt increased by $544 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0.7 bln (negative), 5.2% of market cap
- EV/EBITDA multiple is 9.4x compared to historical level (75th percentile) of 10.8x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -1.3% vs S&P500 +0.2%
------------------------------------------------
#reports #DDD
[3D Systems Corporation](https://eninvs.com/all.php?name=DDD) (3D printing services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185953)
(2025-05-12, After Market Close):
- Revenue -7.8% YoY (vs -3.5% in previous quarter and historical rate -10.4%)
- EBITDA margin -30.5% increased compared to -31.1% same period last year
- Net Debt increased by $38 mln over the past reporting period (15.3% of market cap)
- FCF (LTM) -$0 bln (negative), 15.7% of market cap
- EV/EBITDA multiple is 1.2x compared to historical level (75th percentile) of 2.5x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -29.4% vs S&P500 +0.2%
------------------------------------------------
#reports #DAIO
[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185808)
(2025-04-24, After Market Close):
- Revenue 0% YoY (vs -28.6% in previous quarter and historical rate -2.7%)
- Net Debt decreased by $1 mln over the past reporting period (4.5% of market cap)
- FCF (LTM) -$0 bln (negative), 9.0% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 13.5x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went up +11.4% vs S&P500 +0.1%
------------------------------------------------
#reports #CHGG
[Chegg](https://eninvs.com/all.php?name=CHGG) (Learning platform for schoolchildren and students) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185856)
(2025-05-12, Before Market Open):
- Revenue -30.5% YoY (vs -23.9% in previous quarter and historical rate -9.9%)
- EBITDA -82.4% YoY (vs -123.5% in previous quarter)
- EBITDA margin 2.5% decreased compared to 9.8% same period last year
- Net Debt decreased by $197 mln over the past reporting period (237.8% of market cap)
- FCF (LTM) +$0.2 bln (positive), 282.4% of market cap
- EV/Sales multiple is 0.1x
At the opening of the session the share price went up +1.0% vs S&P500 +2.6%
------------------------------------------------
#reports #CARA
[Cara Therapeutics](https://eninvs.com/all.php?name=CARA) (Medicines Developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185757)
(2025-02-26, After Market Close):
- Revenue +50% YoY (vs -66.7% in previous quarter and historical rate +3.5%)
- EBITDA margin -66.7% increased compared to -1500.0% same period last year
- Net Debt increased by $4 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) -$0 bln (negative), 9.9% of market cap
- EV/Sales multiple is 32.2x
At the opening of the session the share price went down -1.2% vs S&P500 +0.3%
------------------------------------------------
#reports #BW
[Babcock & Wilcox Enterprises](https://eninvs.com/all.php?name=BW) (Specialty Industrial Machinery) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185895)
(2025-05-12, After Market Close):
- Revenue -13% YoY (vs +269.2% in previous quarter and historical rate +22.7%)
- EBITDA +20% YoY (vs -250.0% in previous quarter)
- EBITDA margin 3.3% increased compared to 2.4% same period last year
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 55.5x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went up +1.4% vs S&P500 +0.2%
------------------------------------------------
#reports #BKTI
[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185807)
(2023-05-11, Before Market Open):
- Revenue +5.6% YoY (vs +12.5% in previous quarter and historical rate +32.6%)
- EBITDA margin 15.8% increased compared to 5.6% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 64.1x compared to historical level (75th percentile) of 93.4x
- EV/Sales multiple is 9.2x
At the opening of the session the share price went down -2.2%
------------------------------------------------
#reports #BDSX
[Biodesix](https://eninvs.com/all.php?name=BDSX) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185688)
(2025-05-13, After Market Close):
- Revenue +20% YoY (vs +33.3% in previous quarter and historical rate +23.9%)
- EBITDA margin -44.4% increased compared to -66.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (17.1% of market cap)
- FCF (LTM) +$0 bln (positive), 26.6% of market cap
- EV/Sales multiple is 1.3x
------------------------------------------------
#reports #ATNI
[ATN International](https://eninvs.com/all.php?name=ATNI) (Telecommunications company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185950)
(2025-03-04, After Market Close):
- Revenue -4.3% YoY (vs +266.3% in previous quarter and historical rate +32.1%)
- EBITDA -7.3% YoY (vs -22.0% in previous quarter and historical rate +12.3%)
- EBITDA margin 21.2% decreased compared to 21.9% same period last year
- Net Debt decreased by $3 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0 bln (positive), 7.1% of market cap
- EV/EBITDA multiple is 10.9x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 0.8x
At the opening of the session the share price went up +3.0% vs S&P500 -0.4%
------------------------------------------------
#reports #ASRT
[Assertio](https://eninvs.com/all.php?name=ASRT) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185686)
(2025-05-12, After Market Close):
- Revenue -18.8% YoY (vs +97.0% in previous quarter and historical rate +11.7%)
- EBITDA margin -15.4% decreased compared to 3.1% same period last year
- Net Debt increased by $13 mln over the past reporting period (44.6% of market cap)
- FCF (LTM) +$0 bln (positive), 20.6% of market cap
- EV/EBITDA multiple is 1.3x compared to historical level (75th percentile) of 3.9x
- EV/Sales multiple is -0.1x
At the opening of the session the share price went down -1.0% vs S&P500 +0.2%
------------------------------------------------
#reports #AP
[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185684)
(2025-05-13, After Market Close):
- Revenue -5.5% YoY (vs -6.5% in previous quarter and historical rate +5.8%)
- EBITDA +60% YoY (vs +8400.0% in previous quarter and historical rate +57.9%)
- EBITDA margin 7.7% increased compared to 4.5% same period last year
- Net Debt increased by $138 mln over the past reporting period (292.7% of market cap)
- FCF (LTM) -$0 bln (negative), 14.8% of market cap
- EV/EBITDA multiple is 1x compared to historical level (75th percentile) of 12.8x
- EV/Sales multiple is 0.4x
------------------------------------------------
#reports #AKYA
[Akoya Biosciences, Inc.](https://eninvs.com/all.php?name=AKYA) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185782)
(2025-05-12, After Market Close):
- Revenue -5.6% YoY (vs -19.2% in previous quarter and historical rate +27.5%)
- EBITDA margin -70.6% increased compared to -105.6% same period last year
- Net Debt increased by $7 mln over the past reporting period (14.0% of market cap)
- FCF (LTM) -$0 bln (negative), 63.8% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -0.9% vs S&P500 +0.2%
------------------------------------------------
#reports #AKA
[a.k.a. Brands Holding Corp.](https://eninvs.com/all.php?name=AKA) (Internet Retail) reported for 2025 q1
(2023-11-08, After Market Close):
- Revenue +10.3% YoY (vs +6.7% in previous quarter and historical rate -10.9%)
- EBITDA margin -0.8% increased compared to -5.1% same period last year
- Net Debt increased by $15 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 1.5% of market cap
- EV/EBITDA multiple is 76.3x compared to historical level (75th percentile) of 386.7x
- EV/Sales multiple is 2.8x
At the opening of the session the share price went down -9.9%
------------------------------------------------
#reports #AGEN
[Agenus](https://eninvs.com/all.php?name=AGEN) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185842)
(2024-08-08, Before Market Open):
- Revenue -14.3% YoY (vs -67.9% in previous quarter and historical rate +16.0%)
- EBITDA margin -41.7% increased compared to -107.1% same period last year
- Net Debt decreased by $205 mln over the past reporting period (15.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.1% of market cap
- EV/Sales multiple is 14.2x
At the opening of the session the share price went up +0.8% vs S&P500 +1.0%
------------------------------------------------
#reports #ZI
@ saas
[ZoomInfo Technologies](https://eninvs.com/all.php?name=ZI) (Software developer) reported for 2025 q1
(2025-05-12, After Market Close):
- Revenue -1.3% YoY (vs -2.2% in previous quarter and historical rate +15.0%)
- EBITDA +17.5% YoY (vs +0.9% in previous quarter and historical rate +17.7%)
- EBITDA margin 30.7% increased compared to 25.8% same period last year
- Net Debt increased by $12 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.9% of market cap
- EV/EBITDA multiple is 17.9x compared to historical level (75th percentile) of 35.1x
- EV/Sales multiple is 4.5x
------------------------------------------------
#reports #RPD
@ saas
[Rapid7](https://eninvs.com/all.php?name=RPD) (Analytical software provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185884)
(2025-05-12, After Market Close):
- Revenue +2.4% YoY (vs +5.4% in previous quarter and historical rate +14.3%)
- EBITDA -45.5% YoY (vs -13.6% in previous quarter and historical rate +61.7%)
- EBITDA margin 5.7% decreased compared to 10.7% same period last year
- Net Debt increased by $25 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 28.1x compared to historical level (75th percentile) of 54.8x
- EV/Sales multiple is 2.4x
At the opening of the session the share price went down -5.9% vs S&P500 +0.2%
------------------------------------------------
#reports #PLUG
@ renewable-energy
[Plug Power](https://eninvs.com/all.php?name=PLUG) (Handling equipment manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185841)
(2025-05-12, After Market Close):
- Revenue +11.7% YoY (vs -14.0% in previous quarter and historical rate +9.4%)
- EBITDA margin -134.3% increased compared to -217.5% same period last year
- Net Debt decreased by $477 mln over the past reporting period (74.9% of market cap)
- FCF (LTM) +$0.3 bln (positive), 47.9% of market cap
- EV/Sales multiple is 1.2x
At the opening of the session the share price went down -2.6% vs S&P500 +0.2%
------------------------------------------------
#reports #SE
@ gaming
[Sea](https://eninvs.com/all.php?name=SE) (Electronic Gaming and Multimedia) reported for 2025 q1
(2025-05-13, Before Market Open):
- Revenue +29.6% YoY (vs +36.9% in previous quarter and historical rate +18.0%)
- EBITDA +303.1% YoY (vs +28700.0% in previous quarter and historical rate +82.4%)
- EBITDA margin 10.6% increased compared to 3.4% same period last year
- Net Debt increased by $232 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$3.3 bln (positive), 3.8% of market cap
- EV/EBITDA multiple is 70.1x compared to historical level (75th percentile) of 139x
- EV/Sales multiple is 4.6x
At the opening of the session the share price went up +6.7% vs S&P500 +0.2%
------------------------------------------------
#reports #HUYA
@ china , @ gaming
[HUYA](https://eninvs.com/all.php?name=HUYA) (Entertainment) reported for 2025 q1
(2025-03-18, Before Market Open):
- Revenue 0% YoY (vs -4.7% in previous quarter and historical rate -18.3%)
- EBITDA -21.4% YoY (vs 0.0% in previous quarter and historical rate +17.1%)
- EBITDA margin 5.3% decreased compared to 6.7% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0.3 bln (negative), 30.2% of market cap
- EV/EBITDA multiple is 3x compared to historical level (75th percentile) of 3.4x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -5.3% vs S&P500 -0.4%
------------------------------------------------
#reports #ARTNA
[Artesian Resources Corporation](https://eninvs.com/all.php?name=ARTNA) (Utilities — Regulated Water) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185645)
(2025-05-05, After Market Close):
- Revenue +4% YoY (vs +8.0% in previous quarter and historical rate +5.5%)
- EBITDA +12.5% YoY (vs 0.0% in previous quarter and historical rate -2.2%)
- EBITDA margin 34.6% increased compared to 32.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 4.9x
At the opening of the session the share price went up +1.5% vs S&P500 -0.8%
------------------------------------------------
#reports #RPID
[Rapid Micro Biosystems, Inc.](https://eninvs.com/all.php?name=RPID) (Medical Devices) reported for 2025 q1
(2025-05-09, Before Market Open):
- Revenue +16.7% YoY (vs +33.3% in previous quarter and historical rate +13.8%)
- EBITDA margin -142.9% increased compared to -216.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0 bln (negative), 20.0% of market cap
- EV/Sales multiple is 3.3x
At the opening of the session the share price went up +22.4% vs S&P500 +0.3%
------------------------------------------------
#reports #PAR
[PAR Technology Corporation](https://eninvs.com/all.php?name=PAR) (Restaurant software and hardware solutions provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185461)
(2025-05-09, Before Market Open):
- Revenue -1% YoY (vs -2.8% in previous quarter and historical rate +8.3%)
- EBITDA margin -7.7% increased compared to -18.1% same period last year
- Net Debt increased by $40 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/Sales multiple is 7.1x
At the opening of the session the share price went down -3.1% vs S&P500 +0.3%
------------------------------------------------
#reports #OB
[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for 2025 q1
(2025-05-09, Before Market Open):
- Revenue +31.8% YoY (vs -5.2% in previous quarter and historical rate -2.3%)
- EBITDA margin -14.0% decreased compared to -1.4% same period last year
- Net Debt increased by $645 mln over the past reporting period (375.1% of market cap)
- FCF (LTM) -$0.7 bln (negative), 392.0% of market cap
- EV/Sales multiple is 0.7x
At the opening of the session the share price went down -9.9% vs S&P500 +0.3%
Invest in the next industry-leading mega-growers like Amazon, Facebook, or Zoom
We are screening 2000+ US-listed companies for you, selecting stocks on trajectories for rapid growth
PeriodStrategyS&P500
Day 0.0%0.0%
Week +20.0%+1.7%
Year to date +6.9%+31.4%
Since inception (2020-07-13) -73.2%+98.8%
Maximum drawdown 93.7%
Date of drawdown 2024-08-28
Sharpe ratio -0.26
Volatility (year) 59%
Portfolio (USD) and S&P500 dynamics (%)
| Company | Share | Price -w | Price | Change($) |
|---|---|---|---|---|
| 78.1% | +25.4% | |||
| 17.0% | +4.4% | |||
| 2.5% | +2.6% | |||
| 1.6% | +5.2% | |||
| 0.9% | 0.0% | |||
| Portfolio | +20.0% |
US Leaders: +3.3%
Global Commodities: -2.7%
New companies included in target portfolio:
CF CF Industries
Trending Ideas: +1.2%
Rising Stars: +6.6%
vs S&P500: +3.4%
US Leaders: -1.3%
Global Commodities: -1.1%
Companies that left target portfolio:
IMPUY Impala Platinum
Trending Ideas: -0.4%
Rising Stars: +0.3%
vs S&P500: -0.2%
Kiniksa Pharmac..
Pinduoduo
Intercontinenta..
Jiayin Group
Melco Resorts &..
Liberty Media-L..
Onto Innovation
Catalyst Pharma..
Liberty Media-L..
Liberty Media-L..
